Differentiated thyroid cancer shows a comparable prognosis in patients with immunocompromised vs immunocompetent status, a ...

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...

Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid ...

Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of thyroid cancer, and recent changes in ...

There’s no routine screening test for thyroid cancer, and many people don’t notice any symptoms. But when symptoms do appear, ...

BioAtla, Inc. (NASDAQ:BCAB) Q3 2025 Earnings Call Transcript November 13, 2025 Operator: You all sites on hold. We appreciate your patience, and please continue to stand by. All sites on hold. We ...

Management confirmed pursuit of a major partnership transaction targeted for completion by year-end and disclosed recent FDA alignment on the phase three trial design for OSV in OPSCC, establishing a ...

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics’ commitment to ...

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics' commitment to addressing unmet needs in the neuroendocrine tumor community ...

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory ...

In The Lancet Diabetes & Endocrinology, Mengmeng Li and colleagues analysed global trends in thyroid cancer incidence from 2003 to 2017 and contemporary burden for the year 2022 among adolescents and ...